Max Wolff
Psychologist, psychotherapist and clinician-researcher with research focus on psychedelic therapy
Humboldt-Universität zu Berlin
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max WolffCritical commentary on a recent paper reporting emergence of dissociated traumatic memories during psilocybin treatment now out in the Journal of Eating Disorders, with @trpwolff.bsky.social, @manojdoss.bsky.social, Lilian Kloft-Heller, and @henryotgaar.bsky.social. doi.org/10.1186/s403...
- Reposted by Max Wolff[Not loaded yet]
- In this new commentary, @kangaslampi.bsky.social and I argue against viewing the psychedelic experience as a "biomarker" and challenge reductionistic drug-centered framings that obscure key psychosocial determinants of psychedelic therapy outcome, most notably psychotherapeutic processes. LINK ⬇️
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- To those who dismiss psychodynamic therapy, and perhaps especially to those who dismiss anything except psychodynamic therapy, this article comes highly recommended: psycnet.apa.org/doiLanding?d...
- Reposted by Max Wolff[Not loaded yet]
- New long-read theory paper in Psychological Review: Im short, we propose that effective psychedelic therapy employs the uniquely context-dependent effects of psychedelic drugs to engage & augment the same psychological change processes that underlie all effective psychotherapies. Full text below ⬇️
- Classical randomized controlled trials (RCTs) can't capture the complexity of psychedelic therapy. In this new paper led by @sdmuthu.bsky.social and @tehseennoorani.bsky.social, we argue for pragmatic trials designs that accommodate this complexity and better align with real-world clinical practice.
- Reposted by Max Wolff[Not loaded yet]
- Has the time come to stop using "control groups" in trials of psychological interventions? — asks Pim Cuijpers. This discussion concerns psychedelic therapy, which is a (pharmacologically catalyzed) psychological intervention, just as well as any other form of psychotherapy. Link below.
- From our recent article "Key competencies for psychedelic treatment in real-world mental health care settings" Full-text link below.
- Reposted by Max Wolff[Not loaded yet]
- Our new paper "Key competencies for psychedelic treatment in real-world mental health care settings" has just been published in General Hospital Psychiatry. Full-text link below.
- Reposted by Max Wolff[Not loaded yet]
- Bluesky now platform of choice for science community - except for the psychedelic science community, which seems to have chosen Linkedin. What does this say about psychedelic science?
- Reposted by Max WolffBREAKING: German regulators have green-lit the EU's first psilocybin compassionate access program. Unlike other countries’ pre-approval pathways, Germany’s does not require case-by-case regulatory approval and may see insurers cover costs. Details: psychedelicalpha.com/news/germany...
- Our recent article "Reframing psychedelic regulation: Tools, not treatments" is discussed on the SPACE blog (in Portuguese): space.com.pt/blogue/regul...
- Reposted by Max Wolff[Not loaded yet]
- Small feasibility study testing MDMA-assisted psychotherapy for major depression, unsurprisingly with promising results, from Norway. www.cambridge.org/core/journal...
- Doing psychedelic research with Spanish-speaking populations & interested in avoidance/acceptance? There is now a culturally decentered Spanish APEQ version designed to work equally well across the Spanish-speaking world: www.sciencedirect.com/science/arti...
- Reposted by Max Wolff[Not loaded yet]
- This seems relevant to psychedelic research, where expectancy is still often viewed only as a baseline variable. We should also consider its dynamic changes, how (psychedelic & other) treatment experiences influence them, and their impact on outcomes. @psybalazs.bsky.social @theborislab.bsky.social
- In psychotherapy, treatment expectations matter. But even more powerful? ➡️ How they change over time. Our new paper shows that updating expectations during psychotherapy for MDD predicts depression outcomes. 🔗 www.tandfonline.com/eprint/WRBWU... #depression #psychotherapy #beliefupdating
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- Reposted by Max Wolff[Not loaded yet]
- Reframing Psychedelic Regulation: Tools, not Treatments In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right. The use of anesthetics as treatment tools in surgery is a useful analogy.
